REVERSAL OF CLAVULANATE RESISTANCE CONFERRED BY A SER-244 MUTANT OF TEM-1 BETA-LACTAMASE AS A RESULT OF A 2ND MUTATION (ARG TO SER AT POSITION-164) THAT ENHANCES ACTIVITY AGAINST CEFTAZIDIME

The mutation of Arg-244 to Ser (Arg-244-->Ser mutation) in the TEM-1 b eta-lactamase has been shown to produce resistance to inactivation by clavulanate in the mutant enzyme and resistance to ampicillin plus cla vulanate in a strain of Escherichia coli producing this enzyme. The Ar g-164-->Ser mutation in the TEM-1 beta-lactamase (TEM-12 enzyme) is kn own to enhance the activity of the enzyme against ceftazidime, resulti ng in resistance to the drug in a strain producing the mutant enzyme ( D. A. Weber, C. C. Sanders, J. S. Bakken, and J. P. Quinn, J. Infect, Dis. 162:460-465, 1990). The doubly mutated derivative of the TEM-1 en zyme (Ser-164/Ser-244) retains the characteristics of the Ser-164 muta nt enzyme, i.e., enhanced activity against ceftazidime and sensitivity to inactivation by clavulanate. It also confers the same phenotype as the Ser-164 mutant enzyme, i.e., resistance to ceftazidime and ampici llin, with reversal of this resistance in the presence of clavulanate. Thus, the Arg-164-->Ser mutation in the TEM-1 beta-lactamase suppress es the effect of the Arg-244-->Ser mutation which, by itself, reduces the sensitivity of the enzyme to inactivation by clavulanate.